Current:Home > NewsOlympic skater's doping hearing adjourned in shocking move; more delays ahead -FundPrime
Olympic skater's doping hearing adjourned in shocking move; more delays ahead
View
Date:2025-04-14 23:43:53
LAUSANNE, Switzerland — In a surprising development that will add more than a month at least to the nearly 600-day-long Kamila Valieva doping saga, the Court of Arbitration for Sport abruptly announced late Thursday afternoon that the Russian skater’s hearing had been adjourned until Nov. 9-10.
The reason? The three-member CAS panel “ordered the production of further documentation,” CAS said in a statement given to USA TODAY Sports.
Apparently, one of the parties in the case requested a file that was not previously a part of the proceedings. The timing of that request was a surprise as it came on the day that CAS had thought might bring an end to the hearing and a start to the deliberations by the arbitration panel.
It was unclear which party made the request, but U.S. Anti-Doping Agency CEO Travis Tygart told USA TODAY Sports:
“Of course, we all are for full and complete due process but this reeks of just further manipulation by the Russians and the system has to change to ensure this cannot continue to happen.”
A CAS spokeswoman would not comment on the adjournment beyond the organization’s statement.
A decision by the arbitrators on Valieva’s guilt or innocence was to have been expected within two to three months, but that timeline has now been pushed back to the early months of 2024. That will be nearly two years after Russia won the gold medal, the United States won the silver medal and Japan won the bronze in the team figure skating competition Feb. 7, 2022, at the Beijing Olympics.
The following day, those results were thrown into disarray when Valieva, the then-15-year-old star of the Russian team, was found to have tested positive for the banned substance trimetazidine Dec. 25, 2021, at the Russian championships, forcing the unprecedented cancellation of the event’s medal ceremony.
That’s when time stood still. The rest of 2022 was marked by an infuriating blend of dithering and delays by the sole organization charged with conducting the Valieva investigation, the Russian Anti-Doping Agency, an organization that was suspended from 2015-2018 for helping Russian athletes cheat.
All this time, the athletes from the United States, Japan and of course Russia (and potentially Canada, the fourth-place finisher) have been without their medals.
U.S. Figure Skating CEO Tracy Marek said in a statement to USA TODAY Sports Thursday that the organization “is profoundly disheartened by the news of a delay in the CAS hearing.
“While we recognize the inherent complexities and time requirements of legal processes, the nearly 600-day wait without a resolution is undeniably another painful setback for our dedicated athletes. We emphasize the importance of transparency in this matter, as it greatly impacts our athletes.”
The World Anti-Doping Agency has asked CAS to suspend Valieva for four years and disqualify her Olympic results.
“Due to the confidential nature of the proceedings, WADA is not permitted to comment further on the adjournment announced by the Court of Arbitration for Sport earlier today,” spokesman James Fitzgerald said. “However, as it has done at all stages, it will continue to push for a resolution of these proceedings as quickly as possible.
“WADA took this appeal to CAS in the interests of fairness for athletes and clean sport. Our position in this case has not changed. We maintain that the finding by the disciplinary tribunal of RUSADA that the athlete bore 'no fault or negligence' was wrong under the terms of the World Anti-Doping Code. In accordance with the applicable rules, we continue to seek a four-year period of ineligibility and disqualification of the athlete’s results from the date of the sample collection, including her results during the 2022 Olympic Games in Beijing.”
veryGood! (22)
Related
- Biden administration makes final diplomatic push for stability across a turbulent Mideast
- Life expectancy in the U.S. continues to drop, driven by COVID-19
- Andrew Callegari
- Star Wars Day 2023: Shop Merch and Deals From Stoney Clover Lane, Fanatics, Amazon, and More
- Meet the volunteers risking their lives to deliver Christmas gifts to children in Haiti
- Vanderpump Rules Alum Kristen Doute Weighs In on Tom Sandoval and Raquel Leviss’ Affair
- 300 Scientists Oppose Trump Nominee: ‘More Dangerous Than Climate Change is Lying’
- Wind Power to Nuclear, Team Obama Talks Up a Diverse Energy Portfolio
- Spooky or not? Some Choa Chu Kang residents say community garden resembles cemetery
- N. Richard Werthamer
Ranking
- Most popular books of the week: See what topped USA TODAY's bestselling books list
- Edward E. David
- Harold N. Weinberg
- Science Museums Cutting Financial Ties to Fossil Fuel Industry
- Apple iOS 18.2: What to know about top features, including Genmoji, AI updates
- The government will no longer be sending free COVID-19 tests to Americans
- Bachelor Nation's Peter Weber Confirms Kelley Flanagan Break Up Less Than a Year After Reuniting
- Today’s Climate: May 15-16, 2010
Recommendation
DeepSeek: Did a little known Chinese startup cause a 'Sputnik moment' for AI?
King Charles III Can Carry On This Top-Notch Advice From Queen Elizabeth II
Jamie Foxx Breaks Silence After Suffering Medical Emergency
Amazon's Limited-Time Pet Day Sale Has the Best Pet Deals to Shop From
California DMV apologizes for license plate that some say mocks Oct. 7 attack on Israel
What's behind the FDA's controversial strategy for evaluating new COVID boosters
Wallace Broecker
The monkeypox outbreak may be slowing in the U.S., but health officials urge caution